Literature DB >> 11341962

Presence of a phospholipase D (PLD) distinct from PLD1 or PLD2 in human neutrophils: immunobiochemical characterization and initial purification.

J M Horn1, J A Lehman, G Alter, J Horwitz, J Gomez-Cambronero.   

Abstract

Utilizing the transphosphatidylation reaction catalyzed by phospholipase D (PLD) in the presence of a primary alcohol and the short-chain phospholipid PC8, we have characterized the enzyme from human neutrophils. A pH optimum of 7.8-8.0 was determined. PIP(2), EDTA/EGTA, and ATP were found to enhance basal PLD activity in vitro. Inhibitory elements were: oleate, Triton X-100, n-octyl-beta-glucopyranoside, divalent cations, GTPgammaS and H(2)O(2). The apparent K(m) for the butanol substrate was 0.1 mM and the V(max) was 6.0 nmol mg(-1) h(-1). Immunochemical analysis by anti-pan PLD antibodies revealed a neutrophil PLD of approximately 90 kDa and other bands recognized minimally by anti-PLD1 or anti-PLD2 antibodies. The 90-kDa protein is tyrosine-phosphorylated upon cell stimulation with GM-CSF and formyl-Met-Leu-Phe. Protein partial purification using column liquid chromatography was performed after cell subfractionation. Based on the enzyme's regulatory and inhibitory factors, and its molecular weight, these data indicate an enzyme isoform that might be different from the mammalian PLD1/2 forms described earlier. The present results lay the foundation for further purification of this granulocyte PLD isoform.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11341962     DOI: 10.1016/s1388-1981(00)00172-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2.

Authors:  Nicholas Lehman; Mauricio Di Fulvio; Nicholas McCray; Isabel Campos; Farnaz Tabatabaian; Julian Gomez-Cambronero
Journal:  Blood       Date:  2006-07-27       Impact factor: 22.113

2.  The Grb2/PLD2 interaction is essential for lipase activity, intracellular localization and signaling in response to EGF.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Karen M Henkels; Nicholas Lehman; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2007-01-12       Impact factor: 5.469

Review 3.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

4.  Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells.

Authors:  Luca M Neri; Roberta Bortul; Paola Borgatti; Giovanna Tabellini; Giovanna Baldini; Silvano Capitani; Alberto M Martelli
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

5.  Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.

Authors:  Ramya Ganesan; Madhu Mahankali; Gerald Alter; Julian Gomez-Cambronero
Journal:  Biochim Biophys Acta       Date:  2014-12-20

6.  The elucidation of novel SH2 binding sites on PLD2.

Authors:  M Di Fulvio; N Lehman; X Lin; I Lopez; J Gomez-Cambronero
Journal:  Oncogene       Date:  2006-05-18       Impact factor: 9.867

7.  The uncovering of a novel regulatory mechanism for PLD2: formation of a ternary complex with protein tyrosine phosphatase PTP1B and growth factor receptor-bound protein GRB2.

Authors:  Jeff Horn; Isabel Lopez; Mill W Miller; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2005-06-24       Impact factor: 3.575

8.  Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Karen M Henkels; William C Grunwald; David Cool; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

9.  Measurements of phospholipases A2, C, and D (PLA2, PLC, and PLD). In vitro microassays, analysis of enzyme isoforms, and intact-cell assays.

Authors:  Julian Gomez-Cambronero; Joel Horwitz; Ramadan I Sha'afi
Journal:  Methods Mol Biol       Date:  2003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.